These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 8996599)
1. Clinical development of topoisomerase-interactive drugs. Muggia FM; Burris HA Adv Pharmacol; 1994; 29B():1-31. PubMed ID: 8996599 [No Abstract] [Full Text] [Related]
2. Topoisomerase inhibitors. A review of their therapeutic potential in cancer. Sinha BK Drugs; 1995 Jan; 49(1):11-9. PubMed ID: 7705211 [TBL] [Abstract][Full Text] [Related]
3. The development of camptothecin analogs in childhood cancers. Bomgaars L; Berg SL; Blaney SM Oncologist; 2001; 6(6):506-16. PubMed ID: 11743213 [TBL] [Abstract][Full Text] [Related]
4. Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile. Hartmann JT; Lipp HP Drug Saf; 2006; 29(3):209-30. PubMed ID: 16524321 [TBL] [Abstract][Full Text] [Related]
14. [A symphony for the camptothecins]. Lansiaux A; Bailly C Bull Cancer; 2003 Mar; 90(3):239-45. PubMed ID: 12801826 [TBL] [Abstract][Full Text] [Related]
15. The potential of topoisomerase I inhibitors in the treatment of CNS malignancies: report of a synergistic effect between topotecan and radiation. Lamond JP; Mehta MP; Boothman DA J Neurooncol; 1996 Oct; 30(1):1-6. PubMed ID: 8864997 [TBL] [Abstract][Full Text] [Related]
16. Topoisomerase I inhibitors: topotecan and irenotecan. Creemers GJ; Lund B; Verweij J Cancer Treat Rev; 1994 Jan; 20(1):73-96. PubMed ID: 8293429 [No Abstract] [Full Text] [Related]
17. Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development. Gerrits CJ; de Jonge MJ; Schellens JH; Stoter G; Verweij J Br J Cancer; 1997; 76(7):952-62. PubMed ID: 9328159 [TBL] [Abstract][Full Text] [Related]
18. Clinical trials with the topoisomerase I inhibitors. Burris HA; Rothenberg ML; Kuhn JG; Von Hoff DD Semin Oncol; 1992 Dec; 19(6):663-9. PubMed ID: 1334279 [TBL] [Abstract][Full Text] [Related]
19. Topoisomerase-I inhibitors in the management of colon cancer. Willson JK Ann N Y Acad Sci; 1996 Dec; 803():256-63. PubMed ID: 8993519 [No Abstract] [Full Text] [Related]
20. The evolving role of irinotecan: a broad-spectrum chemotherapeutic agent. Introduction. Ajani JA Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):17-8. PubMed ID: 11200142 [No Abstract] [Full Text] [Related] [Next] [New Search]